[go: up one dir, main page]

AU2001281734A1 - Method for screening highly active proteases and inhibitors - Google Patents

Method for screening highly active proteases and inhibitors

Info

Publication number
AU2001281734A1
AU2001281734A1 AU2001281734A AU8173401A AU2001281734A1 AU 2001281734 A1 AU2001281734 A1 AU 2001281734A1 AU 2001281734 A AU2001281734 A AU 2001281734A AU 8173401 A AU8173401 A AU 8173401A AU 2001281734 A1 AU2001281734 A1 AU 2001281734A1
Authority
AU
Australia
Prior art keywords
protease
gene
inhibitors
highly active
active proteases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281734A
Inventor
Mads Norregaard-Madsen
Poul Erik Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of AU2001281734A1 publication Critical patent/AU2001281734A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)

Abstract

A method of screening a protease gene library for a gene encoding a protease of interest, the method comprising the steps of introducing a first gene of the protease gene library and a second gene encoding a protease inhibitor into a host cell; cultivating the host cell, wherein the cell expresses the first and the second genes to produce a complex of a protease and the inhibitor; dissociating the inhibitor from the complex; and selecting the protease of interest and isolating the encoding gene.
AU2001281734A 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors Abandoned AU2001281734A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001273 2000-08-29
DKPA200001273 2000-08-29
US23001700P 2000-09-05 2000-09-05
US60230017 2000-09-05
PCT/DK2001/000503 WO2002018588A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Publications (1)

Publication Number Publication Date
AU2001281734A1 true AU2001281734A1 (en) 2002-03-13

Family

ID=8159678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281734A Abandoned AU2001281734A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Country Status (7)

Country Link
US (1) US20040038375A1 (en)
EP (1) EP1315806B1 (en)
AT (1) ATE314465T1 (en)
AU (1) AU2001281734A1 (en)
CA (1) CA2419860A1 (en)
DE (1) DE60116337D1 (en)
WO (1) WO2002018588A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080090745A1 (en) * 2006-10-13 2008-04-17 Fox Bryan P Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
CN103842378B (en) 2011-10-12 2018-01-02 三洋化成工业株式会社 Protein protease inhibitor and protein solution and detergent composition containing same
US20170114091A1 (en) * 2014-03-28 2017-04-27 Novozymes A/S Resolubilization of protein crystals at low ph
US12019066B2 (en) * 2016-05-16 2024-06-25 Biomadison, Inc. Assay with synaptobrevin based moiety
WO2017201079A1 (en) 2016-05-16 2017-11-23 Biomadison, Inc. Improved assay with synaptobrevin based moiety
US20210380667A1 (en) * 2018-10-10 2021-12-09 Novozymes A/S Chymotrypsin Inhibitor Variants And The Use Thereof
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001305A1 (en) * 1991-07-09 1993-01-21 Robert Balint A method for the identification of protease inhibitors
US6159688A (en) * 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
JP2002534095A (en) * 1999-01-08 2002-10-15 ブリストル−マイヤーズ スクイブ カンパニー Prokaryotic cell lines designed to observe protease activity

Also Published As

Publication number Publication date
US20040038375A1 (en) 2004-02-26
EP1315806B1 (en) 2005-12-28
EP1315806A1 (en) 2003-06-04
WO2002018588A1 (en) 2002-03-07
ATE314465T1 (en) 2006-01-15
DE60116337D1 (en) 2006-02-02
CA2419860A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU8843701A (en) Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
WO2003102214A3 (en) Method for efficient rna interference in mammalian cells
AU2003261629A1 (en) Method for screening of a lipase having improved enzymatic activity using yeast surface display vector and the lipase
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
AU2645097A (en) Auto-deconvoluting combinatorial libraries
AU2001242299A1 (en) Fungal transcriptional activator useful in methods for producing polypeptides
AU2003238717A1 (en) POLYPEPTIDES HAVING Alpha- H-Alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
WO2005033094A3 (en) Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol
WO2002040685A3 (en) Vectors for conditional gene inactivation
DK1576094T3 (en) Methods for forming modified promoters resulting in varying levels of gene expression
AU2003272800A1 (en) Methods for identifying inhibitors of botulinum neurotoxins
AU2001281734A1 (en) Method for screening highly active proteases and inhibitors
AU2001253376A1 (en) Improved process for the conversion of an aqueous biomass hydrolyzate into fuelsor chemicals by the selective removal of fermentation inhibitors
AU2003231284A1 (en) Seed specific usp promoters for expressing genes in plants
DK1292669T3 (en) New mannanase-producing Bacillus sp. WL-1 strain
WO2008048407A3 (en) Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp.
AU2001260314A1 (en) Method for selecting enzyme inhibitors
WO2002018623A3 (en) Methods and reagents for protease inhibition
AU2001265836A1 (en) Method for genome mining for secreted protein genes
AU2002214085A1 (en) Method for producing proteins by electroporation
MXPA03008984A (en) D-hydantoinase from ochrobactrum anthropi.
WO1999058648A3 (en) Guava (psidium guajava) 13-hydroperoxide lyase and uses thereof
AU2003249320A1 (en) Novel inhibitors of ubiquitin isopeptidases
SE0302840D0 (en) Detection method
WO2003070963A3 (en) Improved protein expression in bacillus subtilis